News and Trends 14 Nov 2022
EpiEndo gets regulatory approval for first patient study of first non-antibiotic macrolide
EpiEndo Pharmaceuticals, a clinical-stage biopharma company developing therapeutics for chronic inflammatory diseases, has received regulatory approval to begin a phase…